vs
纳微半导体（NVTS）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
纳微半导体的季度营收约是Profound Medical Corp.的1.4倍（$8.6M vs $6.0M）
纳微半导体是全球领先的半导体企业，专注于设计生产氮化镓功率集成电路，其高能效、小体积的功率解决方案广泛应用于消费电子、电动汽车、可再生能源、工业领域，服务覆盖北美、亚洲、欧洲的客户。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
NVTS vs PROF — 直观对比
营收规模更大
NVTS
是对方的1.4倍
$6.0M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.6M | $6.0M |
| 净利润 | — | $-8.2M |
| 毛利率 | 98.6% | 66.8% |
| 营业利润率 | -260.6% | -123.3% |
| 净利率 | — | -136.8% |
| 营收同比 | -38.7% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVTSPROF
| Q1 26 | $8.6M | — | ||
| Q4 25 | $7.3M | $6.0M | ||
| Q3 25 | $10.1M | $5.1M | ||
| Q2 25 | $14.5M | $2.0M | ||
| Q1 25 | $14.0M | $2.3M | ||
| Q4 24 | $18.0M | — | ||
| Q3 24 | $21.7M | — | ||
| Q2 24 | $20.5M | — |
净利润NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | $-31.8M | $-8.2M | ||
| Q3 25 | $-19.2M | $-8.0M | ||
| Q2 25 | $-49.1M | $-15.7M | ||
| Q1 25 | $-16.8M | $-10.7M | ||
| Q4 24 | $-39.9M | — | ||
| Q3 24 | $-18.7M | — | ||
| Q2 24 | $-22.3M | — |
毛利率NVTSPROF
| Q1 26 | 98.6% | — | ||
| Q4 25 | 38.1% | 66.8% | ||
| Q3 25 | 37.9% | 77.7% | ||
| Q2 25 | 16.1% | 81.7% | ||
| Q1 25 | 37.9% | 79.2% | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 39.7% | — | ||
| Q2 24 | 39.0% | — |
营业利润率NVTSPROF
| Q1 26 | -260.6% | — | ||
| Q4 25 | -567.3% | -123.3% | ||
| Q3 25 | -192.0% | -176.2% | ||
| Q2 25 | -149.4% | -696.9% | ||
| Q1 25 | -180.5% | -477.0% | ||
| Q4 24 | -216.9% | — | ||
| Q3 24 | -133.6% | — | ||
| Q2 24 | -152.1% | — |
净利率NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | -436.1% | -136.8% | ||
| Q3 25 | -190.2% | -157.7% | ||
| Q2 25 | -338.7% | -792.3% | ||
| Q1 25 | -120.1% | -458.1% | ||
| Q4 24 | -221.7% | — | ||
| Q3 24 | -86.4% | — | ||
| Q2 24 | -109.1% | — |
每股收益（稀释后）NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | $-0.14 | $0.27 | ||
| Q3 25 | $-0.09 | $0.26 | ||
| Q2 25 | $-0.25 | $0.52 | ||
| Q1 25 | $-0.09 | $0.36 | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q2 24 | $-0.12 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $221.0M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $420.0M | $66.4M |
| 总资产 | $481.4M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资NVTSPROF
| Q1 26 | $221.0M | — | ||
| Q4 25 | $236.9M | $59.7M | ||
| Q3 25 | $150.6M | $24.8M | ||
| Q2 25 | $161.2M | $35.2M | ||
| Q1 25 | $75.1M | $46.4M | ||
| Q4 24 | $86.7M | — | ||
| Q3 24 | $98.3M | — | ||
| Q2 24 | $111.7M | — |
总债务NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NVTSPROF
| Q1 26 | $420.0M | — | ||
| Q4 25 | $443.7M | $66.4M | ||
| Q3 25 | $371.0M | $32.1M | ||
| Q2 25 | $388.9M | $39.3M | ||
| Q1 25 | $341.8M | $50.8M | ||
| Q4 24 | $348.0M | — | ||
| Q3 24 | $380.8M | — | ||
| Q2 24 | $388.1M | — |
总资产NVTSPROF
| Q1 26 | $481.4M | — | ||
| Q4 25 | $500.5M | $77.5M | ||
| Q3 25 | $430.2M | $42.3M | ||
| Q2 25 | $449.4M | $49.7M | ||
| Q1 25 | $370.8M | $60.9M | ||
| Q4 24 | $390.0M | — | ||
| Q3 24 | $419.4M | — | ||
| Q2 24 | $439.1M | — |
负债/权益比NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | $-8.1M | $-6.6M | ||
| Q3 25 | $-10.0M | $-9.6M | ||
| Q2 25 | $-11.2M | $-13.7M | ||
| Q1 25 | $-13.5M | $-8.3M | ||
| Q4 24 | $-10.2M | — | ||
| Q3 24 | $-13.7M | — | ||
| Q2 24 | $-15.1M | — |
自由现金流NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-10.7M | — | ||
| Q2 25 | $-11.9M | — | ||
| Q1 25 | $-13.6M | — | ||
| Q4 24 | $-10.8M | — | ||
| Q3 24 | $-14.3M | — | ||
| Q2 24 | $-17.9M | — |
自由现金流率NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | -111.8% | — | ||
| Q3 25 | -106.1% | — | ||
| Q2 25 | -82.2% | — | ||
| Q1 25 | -96.8% | — | ||
| Q4 24 | -59.8% | — | ||
| Q3 24 | -65.9% | — | ||
| Q2 24 | -87.3% | — |
资本支出强度NVTSPROF
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 13.4% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
